On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Neck-Specific Exercises Associated with Pain Reduction for Whiplash-Associated Disorders
General physical activity is often part of the prescription for pain patients. But a new secondary analysis published in The European Journal of Pain shows that for patients with whiplash-associated disorders, neck-specific exercises can be effective and well-tolerated as well.
Genomic Testing to Help ID Esophageal Cancer Patients
Research recently published in the Journal of Molecular Diagnostics reveals a new next-generation sequencing (NGS) test to detect genomic mutations in precarious esophageal tissue – potentially improving early detection in individuals with Barrett's esophagus (BE).
Increased Risk of Left Atrial Appendage Leak with Lariat Ligation Device
A study of left atrial appendage ligations in patients with atrial fibrillation (AF) found that leaks are common when doctors perform the surgery with a device called the Lariat and that those leaks can lead to neurological events.
Has the ACA Triggered a Spike in Colorectal Cancer Screenings?
The Affordable Care Act (ACA) lowering certain financial barriers to care seemed to serve as a catalyst for increased colorectal cancer (CRC) screening in individuals of a lower socioeconomic status (SES), since 2010.
Medicare Millionaires: CMS Releases its Annual Doctor Payment Data
Physicians' total annual Medicare part B fee-for-service payment data for 2013 was released by CMS today. The American Medical Association fears a replay of last year's release when many physicians appeared, inaccurately, to be getting very rich from Medicare payments.
Trials Show Immunotherapies Effective Against Advanced Melanoma
Results from two clinical trials reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 highlighted the potential for immunotherapies nivolumab and pembrolizumab as treatment for advanced melanomas, according to Rene Gonzalez, MD, investigator at the University of Colorado Cancer Center and director of the Melanoma Research Clinics at the CU School of Health, and study.